Pfizer to invest €1.2 billion in Belgian manufacturing plant

Pharmaceutical giant Pfizer is investing 1.2 billion€ over three years at its Belgian plant, in Puurs in Antwerpen province.

Posted mercredi, décembre 7 2022
Pfizer to invest €1.2 billion in Belgian manufacturing plant

The announcement was made last Friday in the presence of Prime Minister Alexander De Croo and Flemish Minister-President Jan Jambon. Pfizer also intends to increase the workforce there by 250 people.   

Pfizer detailed that most of this investment will directly serve the expansion of the production and cold storage capacities as well as packaging department. The new products made at the plant will cover various therapeutic areas including rare diseases, inflammation and immunology.

The Puurs site’s workforce has grown from 2,800 to 4,500 workers since the pandemic began, with the site earning the distinction of producing one of the first Covid-19 vaccines to hit the market in 2020.

In related news, the company is adding around up to 500 jobs at its Irish facility, allowing it to double the output of drugs made at the Dublin plant.